A carregar...
Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction
INTRODUCTION: Alemtuzumab and rabbit antithymocyte globulin (rATG) are being used with increasing frequency as induction agents in kidney transplantation. Using the US Renal Data Base System, we analyzed the safety profile of these agents in the elderly. METHODS: In a cohort of patients transplanted...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3237278/ https://ncbi.nlm.nih.gov/pubmed/22104284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334092 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|